Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Curaleaf Holdings ( (TSE:CURA) ) has provided an update.
Curaleaf reported fourth-quarter 2025 net revenue of $333.1 million, up 5% sequentially and 2% year on year, with gross margin improving to 49% as productivity gains offset ongoing price compression. International revenue rose to $51 million in the quarter, contributing to full-year 2025 revenue of $1.27 billion, adjusted EBITDA of $274.7 million and solid cash generation, even as the company remained loss-making on a GAAP basis.
For the full year, Curaleaf’s international revenue surged 63% to $172.5 million, underscoring the growing importance of overseas markets in its portfolio. Management said the completion of a $500 million debt offering and its “Return to Our Roots” restructuring positions the business to shift from stabilization to growth under its “Built for Growth” strategy, targeting sustainable organic expansion supplemented by selective acquisitions.
The most recent analyst rating on (TSE:CURA) stock is a Buy with a C$4.50 price target. To see the full list of analyst forecasts on Curaleaf Holdings stock, see the TSE:CURA Stock Forecast page.
Spark’s Take on TSE:CURA Stock
According to Spark, TipRanks’ AI Analyst, TSE:CURA is a Neutral.
Curaleaf Holdings’ overall stock score is driven by a mix of financial challenges and technical strengths. The company’s financial performance is hindered by declining revenue and profitability, along with increased leverage. However, positive cash flow generation provides some stability. Technical analysis shows a positive trend, contributing to a higher score. Valuation remains a concern due to ongoing losses. The earnings call highlights international growth, but domestic challenges persist.
To see Spark’s full report on TSE:CURA stock, click here.
More about Curaleaf Holdings
Curaleaf Holdings, Inc. is a leading international provider of consumer cannabis products, operating across U.S. and overseas markets. The company focuses on branded cannabis offerings supported by large-scale cultivation facilities, with an emphasis on improving cultivation economics, merchandising discipline, and brand-led innovation to drive growth.
Average Trading Volume: 1,024,160
Technical Sentiment Signal: Sell
Current Market Cap: C$2.62B
For an in-depth examination of CURA stock, go to TipRanks’ Overview page.